Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Wantai/Innovax Receives NMPA Clinical Trial Approval for Lyophilized Recombinant RSV Vaccine (CHO Cell) – Adjuvant‑Free Pre‑F Protein Candidate Targets Adults Aged 60 and Above
CompanyDrug

Wantai/Innovax Receives NMPA Clinical Trial Approval for Lyophilized Recombinant RSV Vaccine (CHO Cell) – Adjuvant‑Free Pre‑F Protein Candidate Targets Adults Aged 60 and Above

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced that its wholly‑owned subsidiary, Xiamen Innovax Biotech Co., Ltd., has received the Drug Clinical Trial Approval Notice from China's National…

Sansure Biotech's Quadruplex Respiratory Pathogen PCR Kit Wins NMPA Registration – Second Lyophilized Four‑in‑One Test Extends AI‑Driven Respiratory Panel Portfolio to Eight Pathogens

Sansure Biotech’s Quadruplex Respiratory Pathogen PCR Kit Wins NMPA Registration – Second Lyophilized Four‑in‑One Test Extends AI‑Driven Respiratory Panel Portfolio to Eight Pathogens

Guangdong True Health Medical's Gene‑Edited Pig Liver Perfusion Support Sets 144‑Hour Global Record – World's First Prolonged Xenotransplantation Efficacy Validation in Preclinical Acute Liver Failure Model

Guangdong True Health Medical’s Gene‑Edited Pig Liver Perfusion Support Sets 144‑Hour Global Record – World’s First Prolonged Xenotransplantation Efficacy Validation in Preclinical Acute Liver Failure Model

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Vcanbio Receives CDE Approval for VUM02 Clinical Trial in Idiopathic Pulmonary Fibrosis

CompanyDrug

Haisco Pharmaceutical Gets CDE Approval for HSK38008 Prostate Cancer Clinical Study

CompanyDrug

Yiling Pharmaceutical’s G201-Na Receives CDE Approval for Phase Ia Study in Prostate Cancer Treatment

CompanyDrug

AffaMed Digital Initiates Clinical Study for AMD201 at Beijing Tiantan Hospital

CompanyDrug

Allist Pharmaceuticals’ Furmonertinib Receives NMPA Approval for Two Clinical Trials

CompanyDrug

Hutchison China Meditech Initiates Two Phase II Studies for HMPL-453 and Orpathys

CompanyDrug

Biosion Receives FDA Approval for Phase II Study of TSLP mAb BSI-045B

CompanyDrug

Jacobio Pharma Receives Approval for Phase I/IIa Study of LIF mAb in Advanced Solid Tumors

Show More